Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
257.38
+8.83 (3.55%)
At close: Aug 13, 2025, 4:00 PM
257.38
0.00 (0.00%)
After-hours: Aug 13, 2025, 7:00 PM EDT
Penumbra Employees
Penumbra had 4,500 employees as of December 31, 2024. The number of employees increased by 300 or 7.14% compared to the previous year.
Employees
4,500
Change (1Y)
300
Growth (1Y)
7.14%
Revenue / Employee
$284,478
Profits / Employee
$32,823
Market Cap
10.04B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4,500 | 300 | 7.14% |
Dec 31, 2023 | 4,200 | 300 | 7.69% |
Dec 31, 2022 | 3,900 | 100 | 2.63% |
Dec 31, 2021 | 3,800 | 500 | 15.15% |
Dec 31, 2020 | 3,300 | 600 | 22.22% |
Dec 31, 2019 | 2,700 | 500 | 22.73% |
Dec 31, 2018 | 2,200 | 500 | 29.41% |
Dec 31, 2017 | 1,700 | 200 | 13.33% |
Dec 31, 2016 | 1,500 | 400 | 36.36% |
Dec 31, 2015 | 1,100 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PEN News
- 5 days ago - Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025 - Seeking Alpha
- 14 days ago - Penumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference - PRNewsWire
- 14 days ago - Penumbra, Inc. (PEN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Penumbra, Inc. Reports Second Quarter 2025 Financial Results - PRNewsWire
- 21 days ago - Five years after COVID, pharma shares languish in US policy limbo - Reuters
- 6 weeks ago - Penumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025 - PRNewsWire
- 6 weeks ago - Penumbra: AI Meets Aspiration - Why The Stock Is A Structural Winner - Seeking Alpha
- 2 months ago - Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial - PRNewsWire